1. Home
  2. NKTR vs ZYXI Comparison

NKTR vs ZYXI Comparison

Compare NKTR & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • ZYXI
  • Stock Information
  • Founded
  • NKTR 1990
  • ZYXI 1996
  • Country
  • NKTR United States
  • ZYXI United States
  • Employees
  • NKTR N/A
  • ZYXI N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NKTR Health Care
  • ZYXI Health Care
  • Exchange
  • NKTR Nasdaq
  • ZYXI Nasdaq
  • Market Cap
  • NKTR 247.9M
  • ZYXI 265.0M
  • IPO Year
  • NKTR 1994
  • ZYXI N/A
  • Fundamental
  • Price
  • NKTR $0.93
  • ZYXI $8.58
  • Analyst Decision
  • NKTR Buy
  • ZYXI Strong Buy
  • Analyst Count
  • NKTR 3
  • ZYXI 2
  • Target Price
  • NKTR $4.00
  • ZYXI $14.00
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • ZYXI 70.7K
  • Earning Date
  • NKTR 11-07-2024
  • ZYXI 10-24-2024
  • Dividend Yield
  • NKTR N/A
  • ZYXI N/A
  • EPS Growth
  • NKTR N/A
  • ZYXI N/A
  • EPS
  • NKTR N/A
  • ZYXI 0.15
  • Revenue
  • NKTR $93,137,000.00
  • ZYXI $193,665,000.00
  • Revenue This Year
  • NKTR $12.85
  • ZYXI $10.70
  • Revenue Next Year
  • NKTR N/A
  • ZYXI $19.78
  • P/E Ratio
  • NKTR N/A
  • ZYXI $55.86
  • Revenue Growth
  • NKTR 5.53
  • ZYXI 4.21
  • 52 Week Low
  • NKTR $0.47
  • ZYXI $7.15
  • 52 Week High
  • NKTR $1.93
  • ZYXI $13.77
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 33.04
  • ZYXI 55.14
  • Support Level
  • NKTR $0.89
  • ZYXI $8.13
  • Resistance Level
  • NKTR $1.04
  • ZYXI $8.62
  • Average True Range (ATR)
  • NKTR 0.07
  • ZYXI 0.29
  • MACD
  • NKTR -0.00
  • ZYXI 0.04
  • Stochastic Oscillator
  • NKTR 14.81
  • ZYXI 82.93

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: